How hormone therapy affects your quality of life
Part of Brain & nervous system, Cancer, Mental health, Pain, Skin clinical trials.
This study looks at how hormone therapy affects your quality of life. You'll answer questionnaires about your symptoms and well-being over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with stage I, II, or III breast cancer.
- You are currently taking hormone therapy (like Tamoxifen or an aromatase inhibitor) and started it within the last year.
- You are between 18 and 75 years old.
- You are likely to live for more than 3 months after starting treatment.
- You are able to understand the study and follow its instructions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital tool (a smartphone app) to help women and men with early breast cancer manage side effects from hormone therapy. The goal is to improve quality of life during treatment.
This study looks at the potential harms and benefits of hormone (endocrine) therapy in people age 70 and older with early-stage, hormone-receptor–positive breast cancer. It may help doctors choose which hormone treatment approach is safest and most helpful for older patients.
This study looks at how breast cancer surgery affects your quality of life. It includes people with any stage of breast cancer (or at high risk) who need breast surgery under general anesthesia. The goal is to learn how to better support your recovery and well-being.
This trial looks at factors that may predict whether hormone receptor–positive breast cancer will come back after you’ve already completed 5 years of hormone (endocrine) therapy. It may help identify who benefits most from longer treatment and follow-up.
This trial tests if a supervised exercise program can improve quality of life for people with early-stage breast cancer who are currently taking hormone therapy (aromatase inhibitors with or without CDK4/6 inhibitors). It aims to see if exercise helps reduce side effects like fatigue and pain.
This study looks at whether a simple blood test (ctDNA) can tell if your current hormone therapy is starting to stop working, and whether switching to a different hormone therapy early would be better. It aims to keep your cancer under control longer with fewer side effects.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.